Archival of Human Biological Samples in CU-Med Biobank

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04706481

Enrollment

10000

Registered

2021-01-12

Start date

2020-01-01

Completion date

2050-12-01

Last updated

2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Diabetes, Healthy, Heart Diseases, Kidney Diseases, Neurological Diseases or Conditions, Other Disease

Keywords

Biobanking

Brief summary

CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.

Detailed description

CU-Med Biobank will collect and store high-quality specimens from cancer-related or other diseases. All samples are linked to annotated clinical data from approved consented protocols. This system provides researchers with high- quality biological samples and comprehensive clinical, pathological including molecular/genetic information for their research. This standardized CU-Med Biobank is a pivotal bridge to improve the translation of basic research into clinical applications. These findings will contribute to improve prevention, enhance diagnosis, develop new treatment and eventual cure of diseases.

Interventions

PROCEDURESpecimen Collection

Specimens obtained from surgical, phlebotomy or other non-invasive procedure

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Enrolled subjects that have provided signed consent for the specimens and de-identified data to be collected, stored and distributed.

Exclusion criteria

* Subjects without signed informed consent for the specimens and de-identified data to be collected, stored and distributed.

Design outcomes

Primary

Measure	Time frame	Description
To distribute human biospecimens for clinical research	99 years	By using the biological samples from CU-Med Biobank, translational studies can be done.
To discover the pathological mechanism of different acute and chronic diseases such as cancer, stroke, heart disease, dementia & diabetes	99 years	The relationship between different genome/proteome/bacteriome/virome and various diseases can be revealed, thus leading to a better prognostic and diagnostic outcome.

Countries

Hong Kong

Contacts

CONTACTTerry OR, Ph.D

terryor@cuhk.edu.hk852-26285221

CONTACTMarcus LAW, M. Phil

marcuslaw@cuhk.edu.hk852-26285221

STUDY_CHAIRChing Wan MA, MB BChir

Chinese University of Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026